Business · 12/10/2021
Monetary Policy Decision
The Bank of Korea's Monetary Policy Board decided to maintain the Base Rate at 0.75% as of October 12, 2021, citing global economic conditions.
Business · 12/10/2021
The Bank of Korea's Monetary Policy Board decided to maintain the Base Rate at 0.75% as of October 12, 2021, citing global economic conditions.
LATEST SIGNALS
6Business · 10/18/2026
Vale Base Metals has completed a transaction to reconfigure ownership of the Thompson Mine Complex, backed by $200 million in new investments (approximately $280 million CAD). The company retains a minority stake of 18.9% and will continue to operate the mine.
Read summary →Business · 10/18/2026
The proposed Silicosis Prevention and Treatment Act would expand detection, treatment, education, and patient care for workers in the artificial stone manufacturing industry, which has been plagued by the disease.
Read summary →Business · 10/18/2026
Angelalign Technology Inc. has already replaced Torque Ridges components in Europe with improved Pressure Points, and the company expects minimal effect on customers following the Paris court's decision
Read summary →Business · 10/18/2026
Angelalign has already replaced Torque Ridges with its Pressure Points system in Europe, following a Paris court ruling on an unused construction element, Angelalign Technology Inc. (6699.HK) «Angel», has already implemented the upgrade in San Clemente, California, on October 18, 2026
Read summary →Business · 10/18/2026
A French court ruling on a discontinued feature will have a minimal impact on Angelalign customers, as the company has already replaced Torque Ridges with improved pressure points in Europe.
Read summary →Business · 10/18/2026
XellSmart, a South Korean and Chinese biotech company, has announced the completion of Phase II enrollment for its off-the-shelf Parkinson's Disease cell therapy, following the presentation of Phase I results at the International Congress of Parkinson's Disease. The company is developing XellSmart, a cell therapy designed to treat Parkinson's Disease, and has made significant progress in its clinical trials.
Read summary →